Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].

Perea, G

Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]. [electronic resource] - Leukemia Jan 2006 - 87-94 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0887-6924

10.1038/sj.leu.2404015 doi


Acute Disease
Adolescent
Adult
Aged
Child
Child, Preschool
Chromosome Inversion
Chromosomes, Human, Pair 16--genetics
Chromosomes, Human, Pair 21--genetics
Chromosomes, Human, Pair 8--genetics
Cytogenetic Analysis
Female
Flow Cytometry
Follow-Up Studies
Humans
Kinetics
Leukemia, Myeloid--genetics
Male
Middle Aged
Neoplasm, Residual--diagnosis
Prognosis
Recurrence
Reverse Transcriptase Polymerase Chain Reaction
Risk Factors
Survival Rate